Scientists have finally pioneered a way to smuggle potent metabolic medicine directly into cells, effectively bypassing the dangerous systemic side effects that have historically stalled pharmaceutical progress. This breakthrough centers on a sophisticated "Trojan horse" delivery system that
The clinical management of metabolic disorders is undergoing a radical shift as researchers move beyond generic tissue analysis to decode the intricate molecular mechanisms governing individual pancreatic cells. Historically, the medical community viewed type 2 diabetes through the lens of
For a disease that quietly affects nearly half a million Americans each year, a precision antibiotic that erases Borrelia burgdorferi while leaving the microbiome intact would shift Lyme treatment from blunt-force regimens to targeted, durable care that preserves health far beyond the infection
At the very sites where arteries branch and curve, the blood’s mechanical turbulence quietly erodes endothelial defenses while seeding DNA injury that stokes plaque formation yet, paradoxically, also triggers a built-in metabolic countermeasure. New research led by Baylor College of Medicine and
Nineteen protein subunits arranged in a near-perfect circle gripped a frayed DNA end, and that spare geometry—simple, symmetric, and relentless—reshaped how a critical cancer target might be stopped. The ring belonged to Mgm101, a yeast mitochondrial homolog of human RAD52, and under a convergence
Signals from a pivotal trial now cut through the noise of a crowded obesity market, forcing hard questions about where dual agonists belong and how quickly they can reshape care. Obesity has shifted from a lifestyle narrative to a biologic disease with organ-level consequences, most notably in the
